Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

Journal of Psychiatric Research

Volumn 43, Issue 3, 2009, Pages 247-254

  Matrisciano, Francesco ^a   Bonaccorso, Stefania ^a,b   Ricciardi, Angelo ^a,e   Scaccianoce, Sergio ^a   Panaccione, Isabella ^a   Wang, Lily ^d   Ruberto, Amedo ^a   Tatarelli, Roberto ^a   Nicoletti, Ferdinando ^a,c   Girardi, Paolo ^a   Shelton, Richard C ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c IRCCS NEUROMED   (Italy)

^d VANDERBILT UNIVERSITY   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Brain derived neurotrophic factor (BDNF); Depression; Escitalopram; Neuroadaptation; Sertraline; Venlafaxine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; ESCITALOPRAM; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

EID: 57749205200     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.03.014     Document Type: Article

References (43)

1. Altar C.A. Neurotrophins and depression. Trends in Pharmacological Sciences 20 (1999) 59-61
2. American Psychiatric Association. Diagnostic criteria from DSM-IV-TR (2000), American Psychiatric Association, Washington, DC
3. Artigas F., Romero L., de Montigny C., and Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neurosciences 19 (1996) 378-383
4. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (2005) 261-265
5. Aydemir C., Yalcin E.S., Aksaray S., Kisa C., Yildirim S.G., Uzbay T., et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (2006) 1256-1260
6. Bermack J.E., and Debonnel G. Modulation of serotonergic neurotransmission by short-term treatment with sigma ligands. British Journal of Pharmacology 134 (2001) 691-699
7. Bramham C.R., and Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Progress in Neurobiology 76 (2005) 99-125
8. Calabrese F., Molteni R., Maj P.F., Cattaneo A., Gennarelli M., Racagni G., et al. Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32 (2007) 2351-2359
9. Cook R.J., and Farewell V.T. Multiplicity considerations in the design and analysis of clinical trials. Journal of the Royal Statistical Society Series A 159 (1996) 93-110
10. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., et al. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
11. Dishir A., and Kulkarni S.K. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine. Neuroscience Letters 420 (2007) 204-208
12. D'Sa C., and Duman R.S. Antidepressants and neuroplasticity. Bipolar Disorder 4 (2002) 183-194
13. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59 (2006) 1116-1127
14. Duman R.S., and Vaidya V.A. Molecular and cellular actions of chronic electroconvulsive seizures. Journal of ECT 14 (1998) 181-193
15. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 54 (1997) 597-606
16. Endicott J., Cohen J., Nee J., Fleiss J., and Sarantakos S. Hamilton depression rating scale. Extracted from regular and change versions of the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 38 (1981) 98-103
17. Escobar M.L., Figueroa-Guzman Y., and Gomez-Palacio-Schjetnan A. In vivo insular cortex LTP induced by brain-derived neurotrophic factor. Brain Research 991 (2003) 274-279
18. Fabre V., and Hamon M. Mechanisms of action of antidepressants: new data from escitalopram. Encephale 29 (2003) 259-265
19. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
20. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., and Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 255 (2005) 381-386
21. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62
22. Huang T.L., Lee C.T., and Liu Y.L. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. Journal of Psychiatric Research (2007)
23. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 109 (2002) 143-148
24. Karege F., Schwald M., and Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosciences Letters 328 (2002) 261-264
25. Kozisek M.E., Middlemas D., and Bylund D.B. The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment. Neuropharmacology 54 (2008) 251-257
26. Larsen M.H., Hay-Schmidt A., Ronn L.C., and Mikkelsen J.D. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. European Journal of Pharmacology (2007)
27. Lewin G.R., and Barde Y.A. Physiology of the neurotrophins. Annual Review of Neuroscience 19 (1996) 289-317
28. Lindsay R.M., Wiegand S.J., Altar C.A., and Di Stefano P.S. Neurotrophic factors: from molecule to man. Trends in Neurosciences 17 (1994) 182-190
29. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiology of Aging 26 (2005) 115-123
30. Lowther S., De Paermentier F., Horton R.W., Tulloch I.F., and Crompton M.R. Pharmacological differences between selective serotonin reuptake inhibitors: interaction with 5-HT2 and sigma binding sites in human brain in vitro. Federation of European Biochemical Societies Letters 5 (1995) 281
31. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neurosciencei 20 (2000) 9104-9110
32. Manji H.K., Bitran J.A., Masana M.I., Chen G.A., Hsiao J.K., Risby E.D., et al. Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies. Psychopharmacology Bulletin 27 (1991) 199-208
33. Mannari C., Origlia N., Scatena A., Del Debbio A., Catena M., Dell'agnello G., et al. BDNF Level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cellular and Molecular Neurobiology (2008)
34. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
35. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15 (1995) 7539-7547
36. Piccinni A., Marazziti D., Catena M., Domenici L., Del Debbio A., Bianchi C., et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. Journal of Affective Disorder 105 (2008) 279-283
37. Popoli P., Pezzola A., Torvinen M., Reggio R., Pintor A., Scarchilli L., et al. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology 25 (2001) 505-513
38. Rabkin J.K., and Klein D.F. The clinical measurement of depressive disorders. In: Marsella A.J., Hirschfeld R.M.A., and Katz M.M. (Eds). The measurement of depression (1987), Guilford Press, New York 30-81
39. Rantamaki T., Hendolin P., Kankaanpaa A., Mijatovic J., Piepponen P., Domenici E., et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32 (2007) 2152-2162
40. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 54 (2003) 70-75
41. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22 (2002) 3251-3261
42. Trajkovska V., Marcussen A.B., Vinberg M., Hartvig P., Aznar S., and Knudsen G.M. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Research Bulletin 73 (2007) 143-149
43. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., et al. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (2007) 1034-1037